Learn More
Invitrogen™ Human VEGF-165 Recombinant Protein
Description
Mature human VEGF165 was expressed in Pichia pastoris, KM71. GenBank Accession # 003376, amino acids 27 - 191. For protein verification, the expressed protein was N-terminal sequenced and begins with the following 10 amino acids: EGGGQNHHEV. Purity is >95% by SDS-PAGE analyses. Activity: The biological activity of recombinant human VEGF165 was determined by measuring the proliferation of human umbilical vein endothelial cells (HUVEC). Use: For in vitro applications. A dose-response assay should be performed to determine the optimal concentration for specific experiments. Reconstitution and Dilution: Store lyophilized material at 4°C. Reconstitute in 1 mL of distilled or deionized water. Dilute in a buffer-containing carrier protein, aliquot, and store at or below -70°C, avoiding multiple freeze-thaw cycles. PBS with 1% BSA or a neutral media containing <10% FCS are suitable buffers.

Specifications
Specifications
Accession Number | P15692 |
For Use With (Application) | Control, ELISA, Functional Assay, Immunoprecipitation, Western Blot |
Formulation | PBS with no preservative |
Gene ID (Entrez) | 7422 |
Molecular Weight (g/mol) | 19.2 kDa |
Name | Human VEGF-165 |
Quantity | 20 μg |
Source | Yeast |
Regulatory Status | RUO |
Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
Show More |
Safety and Handling
Your input is important to us. Please complete this form to provide feedback related to the content on this product.